Literature DB >> 16167869

Immunity to diphtheria and tetanus in Australia: a national serosurvey.

Heather F Gidding1, Josephine L Backhouse, Margaret A Burgess, Gwendolyn L Gilbert.   

Abstract

OBJECTIVE: To determine immunity to tetanus and diphtheria in the Australian population. DESIGN AND
SETTING: Analysis, using double antigen enzyme immunoassays, of a representative sample of sera (1950 samples tested for diphtheria and 2884 for tetanus) collected opportunistically from Australian laboratories between July 1996 and May 1999. MAIN OUTCOME MEASURE: Immunity to diphtheria and tetanus, defined as negative (susceptible) when the antitoxin level was < 0.01 IU/mL, positive (immune) when it was > or = 0.1 IU/mL, and low positive (partially immune) when it was in the range 0.01-< 0.1 IU/mL.
RESULTS: About 99% of children aged 5-9 years had diphtheria and tetanus antitoxin levels > or = 0.01 IU/mL (immune or partially immune). Antitoxin levels declined with age and generally more markedly for diphtheria than tetanus. For subjects aged 50 years and over, less than 60% were immune or partially immune to diphtheria and less than 75% to tetanus. Men and women had similar diphtheria antitoxin levels, while women had lower levels of tetanus antitoxin compared with men of the same age, with the difference being most marked in the age group > or = 70 years (37% v 60%; P < 0.001).
CONCLUSIONS: Immunity in children appears to be good, but adults, especially older people, may not be adequately protected. Recent changes to the Australian Standard Vaccination Schedule should improve immunity in cohorts now aged < 50 years. However, additional efforts are required to protect those over 50 years (especially travellers), who are most susceptible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167869     DOI: 10.5694/j.1326-5377.2005.tb07059.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  8 in total

1.  The seroepidemiology of tetanus in Catalonia, Spain.

Authors:  A Domínguez; P Plans; J Costa; J Espuñes; N Cardeñosa; L Salleras; A Plasència
Journal:  Med Microbiol Immunol       Date:  2007-01-23       Impact factor: 3.402

2.  Incomplete immunity and missed vaccination opportunities in East African immigrants settling in Australia.

Authors:  Susan A Skull; Joanne Y Y Ngeow; Geoff Hogg; Beverley-Ann Biggs
Journal:  J Immigr Minor Health       Date:  2008-06

3.  Tetanus Immunity among Women Aged 15 to 39 Years in Cambodia: a National Population-Based Serosurvey, 2012.

Authors:  Heather M Scobie; Bunsoth Mao; Sokhal Buth; Kathleen A Wannemuehler; Charlotte Sørensen; Chheng Kannarath; M Harley Jenks; Delynn M Moss; Jeffrey W Priest; Sann Chan Soeung; Michael S Deming; Patrick J Lammie; Christopher J Gregory
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

4.  Adolescent vaccines: Need special focus in India.

Authors:  Ramesh Verma; Pardeep Khanna; Suraj Chawla
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 5.  The genus corynebacterium and other medically relevant coryneform-like bacteria.

Authors:  Kathryn Bernard
Journal:  J Clin Microbiol       Date:  2012-07-25       Impact factor: 5.948

6.  Corynebacterium diphtheriae-infective endocarditis in a patient with an atrial septal defect closure device.

Authors:  Jacinta Ng; Teesha Downton; Natalie Davidson; James Marangou
Journal:  BMJ Case Rep       Date:  2019-05-09

7.  Multilocus sequence typing identifies evidence for recombination and two distinct lineages of Corynebacterium diphtheriae.

Authors:  Frances Bolt; Pamela Cassiday; Maria Lucia Tondella; Aruni Dezoysa; Androulla Efstratiou; Andreas Sing; Aleksandra Zasada; Kathryn Bernard; Nicole Guiso; Edgar Badell; Marie-Laure Rosso; Adam Baldwin; Christopher Dowson
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

8.  Clinical outcomes and healthcare costs of inpatients with tetanus in Korea, 2011-2019.

Authors:  Sook-In Jung; Hyun-Ha Chang; Sohyun Bae; Minsik Go; Yoonjung Kim; Soyoon Hwang; Shin-Woo Kim; Ki Tae Kwon
Journal:  BMC Infect Dis       Date:  2021-03-09       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.